首页 | 本学科首页   官方微博 | 高级检索  
     

继发性肾淀粉样变的发病机制与治疗
引用本文:邓安国,苏华. 继发性肾淀粉样变的发病机制与治疗[J]. 临床内科杂志, 2002, 19(6): 416-419
作者姓名:邓安国  苏华
作者单位:430022,武汉,华中科技大学同济医学院协和医院肾内科
摘    要:继发于慢性炎性疾病等多种疾患的淀粉样变常累及肾脏,表现为大量蛋白尿,并可引起肾病综合征甚至功能衰竭,淀粉沉积物中的淀粉样A纤维以及淀粉样物促进因子,淀粉样P物质,载脂蛋白E,硫酸肝素蛋白多糖等成份参与了疾病的发生与发展,目前关于该疾患的药物治疗,如细胞毒类制剂,秋水仙碱,二甲亚砜的实验和临床研究日趋成熟,肾脏替代治疗的经验也日益丰富。

关 键 词:淀粉样变 肾疾病 治疗
文章编号:1001-9057(2002)06-0416-04
修稿时间:2002-08-05

The pathogenesis and treatment of secondary renal amyloidosis
DENG Anguo,SU Hua. The pathogenesis and treatment of secondary renal amyloidosis[J]. Journal of Clinical Internal Medicine, 2002, 19(6): 416-419
Authors:DENG Anguo  SU Hua
Affiliation:DENG Anguo,SU Hua.Department of Nephrology,Xiehe Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
Abstract:Amyloidosis secondary to chronic inflammatory diseases and other illnesses often involve kidney.The most common presentation is non selective and massive proteinuria,nephrotic syndrome even renal failure.Studies show that amyloid A fibril,amyloid enhancing factor,amyloid P component,apolipoprotein E and heparan sulfate proteoglycans may take part in the occurrence and development of the disease.At present the experimental and clinical researches about the medical treatment of renal amyloidosis, such as cytotoxic drugs,colchicine,dimethyl sulfoxide,become more and more matured.And the experiences about renal replacement therapy become richer and richer.
Keywords:Amyloidosis  Kidney disease/therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号